Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–7 of 7 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT01100502
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California at San Francisco San Francisco, California, United States
- Stanford Cancer Center Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT00848926
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California at Los Angeles Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
NCT00947856
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT01026415
- Conditions
- Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
- Locations
-
- City of Hope Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
Completed
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
NCT00430846
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Washington University St Louis, Missouri, United States
- Weill Cornell Medical College New York, United States
- University of Texas/MD Anderson Cancer Center Houston, Texas, United States
Completed
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
NCT01060904
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States
- MD Anderson Cancer Center / University of Texas Houston, Texas, United States
- British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
NCT01026233
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States